Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin’s lymphoma | Haematologica

摘要

Background Plasma thymus and activation-regulated chemokine is a potential biomarker for classical Hodgkin’s lymphoma. To define its value as a marker to monitor treatment response, we correlated serial plasma thymus and activation-regulated chemokine levels with clinical response in newly diagnosed and relapsed classical Hodgkin’s lymphoma patients.